Company page

Savara, Inc.

Savara, Inc. (ticker: SVRA) is a public company based in the United States, with a market capitalization of approximately $1.13 billion. The company focuses on developing innovative therapies for patients with rare respiratory diseases. Savara is dedicated to improving patient outcomes through its specialized treatments and research initiatives.